Sign In to Follow Application
View All Documents & Correspondence

Pharmaceutical Formulations Comprising A Cyclodextrin

Abstract: Disclosed herein is a liquid pharmaceutical formulation comprising an amylin receptor agonist, a GLP-1 receptor agonist and a cyclodextrin comprising hydroxypropyl substitutions. Said co-formulation may be used for the medical treatment of subjects with overweight or obesity, with or without associated co-morbidities; diabetes, with or without associated comorbidities; cardiovascular diseases, non-alcoholic steatohepatitis (NASH) and cognitive impairment, such as that caused by Alzheimer's disease.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
08 July 2024
Publication Number
30/2024
Publication Type
INA
Invention Field
CHEMICAL
Status
Email
Parent Application

Applicants

NOVO NORDISK A/S
Novo Allé 2880 Bagsværd

Inventors

1. KJELDSEN, Benjamin, Troest
Novo Alle 1 2880 Bagsværd
2. CHRISTOFFERSEN, Stig
Novo Alle 1 2880 Bagsværd
3. HANSEN, Rosa, Rebecca, Erritzøe
Novo Alle 1 2880 Bagsværd

Specification

WHATISCLAIMEDIS:
1. An apparatus for wireless communication at a relay entity, comprising: a memory; and
one or more processors, coupled to the memory, configured to:
establish a wireless communication session with a network entity associated with a visited public land mobile network (VPLMN), wherein the relay entity is configured to perform access node functions and user equipment (UE) functions, and wherein establishing the wireless communication session includes enabling wireless communication for both the access node functions and the UE functions via the VPLMN; and
perform a relay service via the access node functions.
2. The apparatus of claim 1, wherein the one or more processors are further configured to determine whether the access node functions are permitted to operate in the VPLMN.
3. The apparatus of claim 2, wherein the one or more processors are further configured to determine whether the access node functions are permitted to operate in the VPLMN based at least in part on at least one of a provisioned list of preferred public land mobile networks (PLMNs), or a provisioned list of PLMNs in which the access node functions are not permitted to operate.
4. The apparatus of claim 3, wherein each of the preferred PLMNs includes a corresponding priority value.
5. The apparatus of claim 4, wherein the one or more processors are further configured to select the VPLMN based at least in part on a priority value associated with the VPLMN.
6. The apparatus of claim 2, wherein determining whether the access node functions are permitted to operate in the VPLMN is based at least in part on an indication received firom the network entity.
7. The apparatus of claim 6, wherein the indication received firom the network entity is received in response to a request, associated with the UE functions, for the access node functions to operate in the VPLMN.
8. The apparatus of claim 6, wherein establishing the wireless communication session with the network entity associated with the VPLMN is based at least in part on another VPLMN rejecting a request, associated with the UE functions, for the access node functions to operate in the other VPLMN.
9. The apparatus of claim 1, wherein the access node functions are associated with an integrated access and backhaul (IAB) distributed unit (IAB-DU).
10. The apparatus of claim 9, wherein the one or more processors are further configured to establish a connection between the IAB-DU and the network entity.

Documents

Application Documents

# Name Date
1 202447052004-STATEMENT OF UNDERTAKING (FORM 3) [08-07-2024(online)].pdf 2024-07-08
2 202447052004-PRIORITY DOCUMENTS [08-07-2024(online)].pdf 2024-07-08
3 202447052004-POWER OF AUTHORITY [08-07-2024(online)].pdf 2024-07-08
4 202447052004-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105-PCT Pamphlet) [08-07-2024(online)].pdf 2024-07-08
5 202447052004-FORM 18 [08-07-2024(online)].pdf 2024-07-08
6 202447052004-FORM 1 [08-07-2024(online)].pdf 2024-07-08
7 202447052004-DECLARATION OF INVENTORSHIP (FORM 5) [08-07-2024(online)].pdf 2024-07-08
8 202447052004-COMPLETE SPECIFICATION [08-07-2024(online)].pdf 2024-07-08
9 202447052004-Proof of Right [03-01-2025(online)].pdf 2025-01-03
10 202447052004-FORM 3 [03-01-2025(online)].pdf 2025-01-03